medical · 8 min read

Heart Disease & Hearing Loss: The Cardiovascular Link Every Doctor Should Mention

The vascular thread

Cardiovascular disease and adult sensorineural hearing loss share more than co-incidence. The cochlear stria vascularis — the network that supplies blood to the hair cells — is an end-arterial system without collateral supply. Any process that damages small-vessel circulation (diabetes, hypertension, dyslipidemia, atherosclerosis, smoking) potentially damages the cochlea. Multiple population studies show adults with documented cardiovascular disease have 1.5–2× the prevalence of hearing loss of age-matched controls, and progression is faster.

Specific cardiovascular conditions and hearing

Coronary artery disease. Independently associated with faster hearing threshold decline. Statin therapy — through anti-inflammatory and endothelial-protective mechanisms — has been observationally associated with slower hearing decline in cohort studies, though randomised evidence is not yet definitive.

Atrial fibrillation. Increases risk of small vascular events including cochlear microinfarcts. Some sudden sensorineural hearing loss cases have atrial fibrillation as an identified precipitant.

Peripheral vascular disease and smoking. Nicotine constricts cochlear microvasculature and independently worsens hearing thresholds. Smoking cessation is one of the most under-utilised hearing-preservation interventions in Indian practice.

Congestive heart failure with reduced ejection fraction. Occasionally requires high-dose loop diuretics, which are ototoxic — see our ototoxic medications guide.

Why the ACHIEVE trial matters here

The 2023 ACHIEVE trial recruited from a cardiovascular disease population precisely because these adults are at elevated dementia risk. The trial found hearing intervention reduced 3-year cognitive decline by roughly 48% in this cohort. The implication: cardiovascular patients with hearing loss are the population where hearing aids matter most for cognitive protection.

Practically, this means every cardiology follow-up over age 55 should include a simple hearing screening question, and any positive should route to an audiogram. Conversely, every audiogram in an adult should screen for cardiovascular risk factors — the two systems are inseparable clinically.

What HearClear coordinates for cardiovascular patients

We routinely coordinate hearing aid fittings for cardiology patients at Escorts, Fortis, Max, Apollo, Medanta, Manipal and other tertiary cardiology programmes. The clinical priorities are: verified audibility (Real Ear Measurement essential), Signia Styletto IX 3IX or 5IX for good speech-in-noise handling, Signia app remote fine-tuning so cardiac patients minimise clinic trips, and dual-programme setup for TV vs restaurant use.

If any of the above matches your experience, book a free clinical hearing assessment. Our Signia Certified audiologists are RCI-registered and offer home visits across 195+ Indian cities — the audiogram is diagnostic and always free.

This article is a plain-language summary reviewed against ASHA (American Speech-Language-Hearing Association), IJOHNS (Indian Journal of Otolaryngology and Head & Neck Surgery), BSA (British Society of Audiology) and Signia clinical documentation. It is educational only. Any concerning symptoms warrant an in-person evaluation by an ENT physician and an RCI-registered audiologist.